Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients
Open Access
- 12 January 2012
- journal article
- research article
- Published by Bioscientifica in Endocrine-Related Cancer
- Vol. 19 (2) , 149-155
Abstract
Head and neck paragangliomas (HNPGLs) are neural crest-derived tumors. In comparison with paragangliomas located in the abdomen and the chest, which are generally catecholamine secreting (sPGLs) and sympathetic in origin, HNPGLs are, in fact, parasympathetic in origin and are generally nonsecreting. Overall, 79 consecutive patients with HNPGL were examined for mutations in SDHA, SDHB, SDHC, SDHD, SDHAF2, VHL, MAX, and TMEM127 genes by PCR/sequencing. According to a detailed family history (FH) and clinical, laboratory (including metanephrines), and instrumental examinations, patients were divided into three groups: a) patients with a positive FH for HNPGL (index cases only), b) patients with a negative FH and multiple HNPGLs (synchronous or metachronous) or HNPGL associated with an sPGL, and c) patients with negative FH and single HNPGL. The ten patients in group a) proved to be SDHD mutation carriers. The 16 patients in group b) proved to be SDHD mutation carriers. Among the 53 patients in group c), ten presented with germ-line mutations (three SDHB, three SDHD, two VHL, and two SDHAF2). An sPGL was found at diagnosis or followed up in five patients (6.3%), all were SDHD mutation carriers. No SDHC, SDHA, MAX, and TMEM127 mutations were found. In SDHD mutation carriers, none of the patients affected by HNPGL associated with sPGL presented missense mutations. In conclusion, a positive FH or the presence of multiple HNPGLs is a strong predictor for germ-line mutations, which are also present in 18.8% of patients carefully classified as sporadic. The most frequently mutated gene so far is SDHD but others, including SDHB, SDHAF2, and VHL, may also be affected.Keywords
This publication has 21 references indexed in Scilit:
- Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytomaNature Genetics, 2011
- SDHA is a tumor suppressor gene causing paragangliomaHuman Molecular Genetics, 2010
- SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytomaThe Lancet Oncology, 2010
- Parasympathetic Paragangliomas Are Part of the Von Hippel-Lindau SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2009
- The Succinate Dehydrogenase Genetic Testing in a Large Prospective Series of Patients with ParagangliomasThe Journal of Clinical Endocrinology & Metabolism, 2009
- Head and Neck Paragangliomas in Von Hippel-Lindau Disease and Multiple Endocrine Neoplasia Type 2The Journal of Clinical Endocrinology & Metabolism, 2009
- Uncommon clinical presentations of pheochromocytoma and paraganglioma in two different patients affected by two distinct novel VHL germline mutationsClinical Endocrinology, 2007
- Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomasJournal of Medical Genetics, 2002
- Gene Mutations in the Succinate Dehydrogenase Subunit SDHB Cause Susceptibility to Familial Pheochromocytoma and to Familial ParagangliomaThe American Journal of Human Genetics, 2001
- Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary ParagangliomaScience, 2000